Encision Inc. Announces Fiscal 2026 Third Quarter Results

Core Insights - Encision Inc. reported a decline in revenue for its 2026 fiscal third quarter, primarily due to the replacement of its surgical procedures by robotic surgeries [1] Financial Performance - The company’s financial results indicate a continued revenue decline, which is attributed to the increasing adoption of surgical robots in the medical field [1] Technology Impact - Encision's patented Active Electrode Monitoring (AEM®) Technology is designed to prevent dangerous radiant energy burns during minimally invasive surgeries, highlighting the importance of its technology in the surgical landscape [1]